Luxembourg June 2020,
Xeon International has been appointed as the Financial Advisor for a new €10 Million Healthcare Investment.
Marcel de Bresser, Chief Business Development at Xeon International comments: ” Investors are very eager to look at investing in the production of CBD for the European Market.The anticipated demand for this new commodity is expected to double in size what is today the largest commodity namely coffee.”
“The Israeli management team has a large experience with the optimisation of the CBD values.” It is the aim to set up a Medicinal CBD manufacturing unit to serve the European market in the initial stage.”
Xeon International aims to create long-term business value for its clients and investors by offering a unique blend of result-oriented, risk sharing strategic value creation and implementation services. It operates within five functional areas: Corporate Finance – Private Equity – Advisory -Commodity Trading and Personal Advisory services.